DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Szanto K, Molnar T, Farkas K.
New promising combo therapy in inflammatory bowel diseases refractory to anti-TNF agents: cyclosporine plus vedolizumab.
J Crohns Colitis 2018;
12: 629
We do not assume any responsibility for the contents of the web pages of other providers.